Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALUTOX: OnabotulinumtoxinA vs Aluminium Chloride for Residual Limb Hyperhidrosis
NCT03433859Phase 3Completed
- Sponsor
- French Defence Health Service
- Start
- Mar 2016
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in hyperhidrosis, sponsored by French Defence Health Service. Started Mar 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on NCT03433859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03433859.